COVID-19 Enfeksiyonu Semptomları ve Tanısı

Authors

Aysu Ayrancı
https://orcid.org/0000-0002-8939-336X
Melike Yüksel Yavuz

Synopsis

COVID-19 infection can be asymptomatic or classified as mild, moderate, severe, and critical disease in symptomatic cases. The most common symptoms are fever, dry cough, and fatigue, accompanied by loss of taste and smell, shortness of breath, sore throat, muscle pain, as well as gastroenterological and neurological manifestations. Male gender, individuals over 50 years of age, comorbid conditions such as cardiovascular disease, diabetes, and obesity, along with genetic factors like TMPRSS2 expression, directly influence symptom severity and individual susceptibility. By entering cells via ACE-2 receptors highly expressed in the respiratory mucosa, COVID-19 leads to multisystemic damage affecting the cardiovascular, renal, and central nervous systems, primarily targeting the respiratory tract. In the diagnostic approach, clinical suspicion and standardized case definitions serve as the initial step, while the gold standard for definitive diagnosis remains the detection of SARS-CoV-2 RNA in respiratory specimens using RT-PCR. Combined nasopharyngeal and oropharyngeal swabs are predominantly preferred for sampling, whereas serological antibody tests (IgM, IgG) play a supportive role when molecular tests are negative, as well as for retrospective diagnosis and immunity assessment.

References

Oran DP, Topol EJ. The Proportion of SARS-CoV-2 Infections That Are Asymptomatic: A Systematic Review. Ann Intern Med 2021.

National Health Commission of People’s Republic of China.Diagnostic and treatment planofCoronavirusdisease2019.7thed. (03.2021 tarihindehttp://www.nhc.gov.cn/yzygj/s7653p/202003/.shtml’ den ulaşılmıştır).

Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020; 323:1239.

Clinical Spectrum of SARS-CoV-2 Infection. Retrieved from (Last Updated: December 17, 2020) (03.2021 tarihindehttps://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/.html’ den ulaşılmıştır.)

Manaf Al-Q, Salman A, AbdulKarim A, et al. The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects. Int J Infect Dis. 2021 Jan; 102: 285–288.

Lauer SA, Grantz KH, Bi Q, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020 May 5;172(9):577–82.

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395:1054-1062.

Centers for Disease Control and Prevention. People who are at higher risk for severe illness. (Accessed on April 01, 2020). (03.2021 tarihinde https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-at-higher-risk.html ulaşılmıştır).

Lauer SA, Grantz KH, Bi Q, Jones FK, , et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med 2020; 172:577–82.

Sama IE, Ravera A, Santema BT, et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors. Eur Heart J. 2020; 41:1810–1817.

He X, Cheng X, Feng X, et al. Clinical Symptom Differences Between Mild and Severe COVID-19 Patients in China: A Meta-Analysis. Front Public Health. 2021; 8:561264.

Matsuyama S, Nao N, Shirato K, et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci USA 117: 7001–7003, 2020.

Saghazadeh A, Rezaei N. Immune-epidemiological parameters of the novel coronavirus -a perspective. Expert Rev Clin Immunol 16: 465–470, 2020.

COVID-19 (SARS-CoV-2 Enfeksiyonu) Genel Bilgiler, Epidemiyoloji ve Tanı Rehberi, (syf:17) T.C. Sağlık Bakanlığı 7 Aralık 2020, Ankara.

Coronavirus disease (COVID-19) 12 October 2020. (03.2021 tarihinde https://www.who.int/emergencies/diseases/novel-coronavirus-2019/.html ulaşılmıştır.)

Andrea L, Cosimo de F. Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms. Ear, Nose & Throat Journal 1–8. 2020.

Ollarves-Carrero MF, Rodriguez-Morales AG, Bonilla-Aldana DK, et al. Anosmia in a healthcare worker with COVID-19 in Madrid, Spain. Travel Med Infect Dis 35:101666

Al-Ani RM, Acharya D. Prevalence of Anosmia and Ageusia in Patients with COVID-19 at a Primary Health Center, Doha, Qatar [published online ahead of print, 2020 Aug 19]. Indian J Otolaryngol Head Neck Surg. 2020;1-7. doi:10.1007/s12070-020-02064-9.

Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020. https://doi.org/10.1056/NEJMoa2002032.

Luca C, Aurelio S, Ahmed N, et al. Pulmonary post-mortem findings in a large series of COVID-19 cases from Northern Italy. medRxiv 2020.04.19.20054262.

Walid H, Malik B, Agnieszka B, et al. Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19. Journal of Molecular and Cellular Cardiology 153 (2021) 72–85.

Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 Case Surveillance- United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:759.

Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Inf Secur. 2020;80(6):656–65.

Cole-Jeffrey C.T., Liu M., Katovich M.J, et al. ACE2 and microbiota: emerging targets for cardiopulmonary disease therapy. J Cardiovasc Pharmacol. 2015; 66:540–550.

Mao R, Qiu Y, He JS, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020; 5:667–78. 10.1016 / S2468-1253 (20) 30126-6.

Rokkas T. Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis. Ann Gastroenterol. 2020;33(4):355-365.

Khoshdel-Rad N., Zahmatkesh E., Shpichka A, et al. Outbreak of chronic renal failure: will this be a delayed heritage of COVID-19? J Nephrol. 2020:1–3.

Bansal M. Kardiyovasküler hastalık ve COVID-19. Diabetes Metab Syndr. 2020; 14: 247–250.

Soumya R. S, Govindan Unni T, Raghu K. G. Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports. Cardiovasc Drugs Ther. 2020 Sep 14: 1–15.

Bader F, Manla Y, Atallah B, et al. Heart failure and COVID-19. Heart Fail Rev. 2021 Jan;26(1):1-10.

Banu Özen B, İlknur Güçlü A. COVID-19 ile İlişkili Nörolojik Komplikasyonlar South. Clin. Ist. Euras. 2020;31(Suppl):26-30.

Berlit, P, Bösel, J, Gahn, G, et al. Neurological manifestations of COVID-19- guideline of the German society of neurology. Neurol. Res. Pract. 2, 51 (2020).

Hai-Yang W, Xue-Lin L, Zhong-Rui Y, et al. Potential neurological symptoms of COVID-19. Ther Adv Neurol Disord 2020, Vol. 13: 1–2.

Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 Case Surveillance- United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:759.

Mark A E, Laura B, Bhagteshwar S, et al. Neurological associations of COVID-19. Lancet Neurol 2020; 19: 767–83.

Tamar W, Nicole H. The neurological symptoms of COVID-19: a systematic overview of systematic reviews, comparison with other neurological conditions and implications for healthcare services. Article in Therapeutic Advances in Chronic Disease · January 2021.

Mao L, Wang M, Chen S, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. JAMA Neurol. (2020) 77:683–90.

Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Military Medical Research. 2020;7(1):11.

Fadaka AO, Sibuyi NRS, Adewale OB, et al. Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2. The Journal of international medical research. 2020;48(8):300060520949077.

Shang J, Wan Y, Luo C, et al. Cell entry mechanisms of SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America. 2020;117(21):11727-34.

Gordon DE, Jang GM, Bouhaddou M, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459-68.

WHO (2021). WHO Coronavirus (COVID-19) Dashboard. (15.05.2021 tarihinde https://covid19.who.int/ adresinden ulaşılmıştır).

Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England journal of medicine. 2020;382(8):727-33.

Mao K, Zhang H, Yang Z. Can a Paper-Based Device Trace COVID-19 Sources with Wastewater-Based Epidemiology? Environmental science & technology. 2020;54(7):3733-5.

Struyf T, Deeks JJ, Dinnes J, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. The Cochrane database of systematic reviews. 2020;7(7):Cd013665.

Cohen PA, Hall LE, John JN, Rapoport AB. The Early Natural History of SARS-CoV-2 Infection: Clinical Observations From an Urban, Ambulatory COVID-19 Clinic. Mayo Clinic proceedings. 2020;95(6):1124-6.

Tostmann A, Bradley J, Bousema T, et al. Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2020;25(16).

Makaronidis J, Mok J, Balogun N, et al. Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study. PLoS medicine. 2020;17(10):e1003358.

Sağlık Bakanlığı (2020). Covid-19 Rehberi Genel Bilgiler, Epidemiyoloji ve Tanı. (07.12.2020 tarihinde https://covid19.saglik.gov.tr/Eklenti/39551/0covid-19rehberigenelbilgiler epidemiyolojivetanipdf. pdf adresinden ulaşılmıştır).

Lumley SF, O'Donnell D, Stoesser NE, et al. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers. The New England journal of medicine. 2021;384(6):533-40.

Shereen MA, Khan S, Kazmi A, et al. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of advanced research. 2020;24:91-8.

Lauer SA, Grantz KH, Bi Q, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of internal medicine. 2020;172(9):577-82.

Adhikari SP, Meng S, Wu YJ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious diseases of poverty. 2020;9(1):29.

Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730-41.

Akinbami LJ, Petersen LR, Sami S, et al. COVID-19 symptoms and SARS-CoV-2 antibody positivity in a large survey of first responders and healthcare personnel, May-July 2020. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021.

He X, Lau EHY, Wu P, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nature medicine. 2020;26(5):672-5.

Ganyani T, Kremer C, Chen D, et al. Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2020;25(17).

Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465-9.

WHO (2020). Diagnostic testing for SARS-CoV-2. (05.11.2020 tarihinde https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2 adresinden ulaşılmıştır).

Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. Jama. 2020;323(18):1843-4.

Cevik M, Bamford CGG, Ho A. COVID-19 pandemic-a focused review for clinicians. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020;26(7):842-7.

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395(10223):497-506.

Pan Y, Zhang D, Yang P, et al. Viral load of SARS-CoV-2 in clinical samples. The Lancet Infectious diseases. 2020;20(4):411-2.

Sutjipto S, Lee PH, Tay JY, et al. The Effect of Sample Site, Illness Duration, and the Presence of Pneumonia on the Detection of SARS-CoV-2 by Real-time Reverse Transcription PCR. Open forum infectious diseases. 2020;7(9):ofaa335.

COVID-19 Investigation Team. Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States. Nature medicine. 2020;26(6):861-8.

Lai CKC, Chen Z, Lui G, et al. Prospective Study Comparing Deep Throat Saliva With Other Respiratory Tract Specimens in the Diagnosis of Novel Coronavirus Disease 2019. The Journal of infectious diseases. 2020;222(10):1612-9.

Hammitt LL, Kazungu S, Welch S, et al. Added value of an oropharyngeal swab in detection of viruses in children hospitalized with lower respiratory tract infection. Journal of clinical microbiology. 2011;49(6):2318-20.

Ek P, Böttiger B, Dahlman D, et al. A combination of naso- and oropharyngeal swabs improves the diagnostic yield of respiratory viruses in adult emergency department patients. Infectious diseases (London, England). 2019;51(4):241-8.

Goff J, Rowe A, Brownstein JS, et al. Surveillance of Acute Respiratory Infections Using Community-Submitted Symptoms and Specimens for Molecular Diagnostic Testing. PLoS currents. 2015;7.

Wang WK, Chen SY, Liu IJ, et al. Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerging infectious diseases. 2004;10(7):1213-9.

To KK, Lu L, Yip CC, et al. Additional molecular testing of saliva specimens improves the detection of respiratory viruses. Emerging microbes & infections. 2017;6(6):e49.

Wyllie AL, Fournier J, Casanovas-Massana A, et al. Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. The New England journal of medicine. 2020;383(13):1283-6.

Weissleder R, Lee H, Ko J, et al. COVID-19 diagnostics in context. Science translational medicine. 2020;12(546).

FDA (2020). False Positive Results with BD SARS-CoV-2 Reagents for the BD Max System - Letter to Clinical Laboratory Staff and Health Care Providers. (10.07.2020 tarihinde https://www.fda.gov/medical-devices/letters-health-care-providers/false-positive-results-bd-sars-cov-2-reagents-bd-max-system-letter-clinical-laboratory-staff-and adresinden ulaşılmıştır).

Chen W, Lan Y, Yuan X, et al. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerging microbes & infections. 2020;9(1):469-73.

Ling Y, Xu SB, Lin YX, et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chinese medical journal. 2020;133(9):1039-43.

Yan Y, Chang L, Wang L. Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures. Reviews in medical virology. 2020;30(3):e2106.

Zhang W, Du RH, Li B, , et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerging microbes & infections. 2020;9(1):386-9.

Wu Y, Guo C, Tang L, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. The lancet Gastroenterology & hepatology. 2020;5(5):434-5.

Chen C, Gao G, Xu Y, et al. SARS-CoV-2-Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19. Annals of internal medicine. 2020;172(12):832-4.

Gupta S, Parker J, Smits S, et al. Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2020;22(6):611-20.

Yongchen Z, Shen H, Wang X, et al. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients. Emerging microbes & infections. 2020;9(1):833-6.

Atkinson B, Petersen E. SARS-CoV-2 shedding and infectivity. Lancet (London, England). 2020;395(10233):1339-40.

Lescure FX, Bouadma L, Nguyen D, , et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. The Lancet Infectious diseases. 2020;20(6):697-706.

Lui G, Ling L, Lai CK, et al. Viral dynamics of SARS-CoV-2 across a spectrum of disease severity in COVID-19. The Journal of infection. 2020;81(2):318-56.

Chang L, Zhao L, Gong H, et al. Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations. Emerging infectious diseases. 2020;26(7):1631-3.

Kwon SY, Kim EJ, Jung YS, et al. Post-donation COVID-19 identification in blood donors. Vox sanguinis. 2020;115(8):601-2.

Caruana G, Croxatto A, Coste AT, et al. Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020;26(9):1178-82.

The Centre for Evidence-Based Medicine (2020). What tests could potentially be used for the screening , diagnosis and monitoring of COVID-19 and what are their advantages and disadvantages. (20.04.2020 tarihinde https://www.cebm.net/covid-19/what-tests-could-potentially-be-used-for-the-screening-diagnosis-and-monitoring-of-covid-19-and-what-are-their-advantages-and-disadvantages/ adresinden ulaşılmıştır).

Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for SARS-CoV-2. Jama. 2020;323(22):2249-51.

Kucirka LM, Lauer SA, Laeyendecker O, et al. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure. Annals of internal medicine. 2020;173(4):262-7.

Hong KH, Lee SW, Kim TS, et al. Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea. Annals of laboratory medicine. 2020;40(5):351-60.

Tang YW, Schmitz JE, Persing DH, et al. Laboratory Diagnosis of COVID-19: Current Issues and Challenges. Journal of clinical microbiology. 2020;58(6).

Lippi G, Simundic AM, at al. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clinical chemistry and laboratory medicine. 2020;58(7):1070-6.

Patel R, Babady E, Theel ES, et al. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19. mBio. 2020;11(2).

Chan CM, Tse H, Wong SS, et al. Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2009;45(1):54-60.

Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology (Carlton, Vic). 2003;8 Suppl(Suppl 1):S9-14.

Liu Y, Eggo RM, Kucharski AJ. Secondary attack rate and superspreading events for SARS-CoV-2. Lancet (London, England). 2020;395(10227):e47.

Roda A, Cavalera S, Di Nardo F, et al. Dual lateral flow optical/chemiluminescence immunosensors for the rapid detection of salivary and serum IgA in patients with COVID-19 disease. Biosensors & bioelectronics. 2021;172:112765.

CDC (2021). Interim Guidelines for Collecting and Handling of Clinical Specimens for COVID-19 Testing. (26.02.2021 tarihinde https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html adresinden ulaşılmıştır).

Stowell SR, Guarner J. Role of Serology in the Coronavirus Disease 2019 Pandemic. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020;71(8):1935-6.

Bryant JE, Azman AS, Ferrari MJ, et al. Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward. Science immunology. 2020;5(47).

Mulchandani R, Jones HE, Taylor-Phillips S, et al. Accuracy of UK Rapid Test Consortium (UK-RTC) "AbC-19 Rapid Test" for detection of previous SARS-CoV-2 infection in key workers: test accuracy study. BMJ (Clinical research ed). 2020;371:m4262.

Pages

255-276

Published

October 29, 2021

License

License